摘要
心血管疾病是慢性肾病(CKD)甚至是肾移植术后人群死亡的主要原因,核素心肌灌注显像(MPI)对心肌血流灌注的评估可以预测一系列的心血管事件,并可用于心血管疾病的危险分层。通过MPI早期识别并个体化治疗心脏事件高风险的患者可预防心肌梗死和心力衰竭,最终达到提高该类人群生存率的目的。该文就MPI在CKD及肾移植人群中的应用进行综述。
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease(CKD)or even those after renal transplantation.Radionuclide myocardial perfusion imaging(MPI)is an available way to predict cardiac events and make risk stratification for CKD patients with cardiovascular diseases.Early detection and individualized treatment of patients with high-risk of cardiac events by MPI can prevent myocardial infarction and heart failure,thus improving the survival rate of this population.This article reviews the application of MPI in patients with CKD.
作者
孙茉茉
沈婕
Sun Momo;Shen Jie(Department of Nuclear Medicine,Tianjin First Center Hospital,Tianjin 300192,China)
出处
《中华核医学与分子影像杂志》
CAS
北大核心
2020年第2期108-112,共5页
Chinese Journal of Nuclear Medicine and Molecular Imaging
基金
天津市科技计划项目(16ZXMJSY00170)。
关键词
肾病
慢性病
心肌灌注显像
发展趋势
Nephrosis
Chronic disease
Myocardial perfusion imaging
Trends
